Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

1883 Cobimetinib
88608b3603905fbcfe1756fc1fc051a0258f9b4ce84d2b901abde323dc8f2fa2

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Cobimetinib, sold under the brand name Cotellic, is a MEK inhibitor developed by Exelixis and Genentech (Roche). It is used in combination with vemurafenib, a BRAF inhibitor, to treat melanoma. In November 2015, the U.S. Food and Drug Administration approved cobimetinib for unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib (Zelboraf). Cobimetinib is not indicated for treatment of patients with wild-type BRAF melanoma.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
1882 Next ≫
1884
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan